Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Ibrutinib
96%
Patient
90%
Laboratory
44%
Combination Therapy
37%
Diffuse Large B-Cell Lymphoma
34%
Bruton Tyrosine Kinase
32%
B Lymphocyte Receptor
32%
Neoplasm
31%
Inpatient
30%
Therapeutic Procedure
29%
Monitoring
29%
Programmed Cell Death
29%
Mantle Cell Lymphoma
28%
Chronic Myelogenous Leukemia
27%
Molecular Pathology
24%
Prognosis
23%
Polymerase Chain Reaction
22%
Polycythemia vera
22%
Leukemia Cell
21%
B Cell
21%
Disease
20%
Allele
20%
Lymphoma Cell
19%
Dasatinib
18%
Biological Marker
18%
Janus Kinase
17%
Diagnosis
17%
Client
17%
Non-Hodgkin Lymphoma
17%
Association
16%
Bone Marrow
14%
Microenvironment
14%
Herpesviridae
14%
Peroxisome Proliferator Activated Receptor
14%
Kaposi Sarcoma
14%
Cancer
14%
Assay
13%
Clinical Trial
13%
Analysis
13%
Interactome
12%
Patient Care
12%
Tumor Cell
12%
Phosphotransferase
12%
Targeted Therapy
12%
Bruton Tyrosine Kinase Inhibitor
11%
Myeloproliferative Disorder
11%
Chronic Lymphocytic Leukemia
11%
Drug Resistance
11%
Cells
11%
Biochemistry, Genetics and Molecular Biology
Mutation
66%
Janus Kinase
22%
Messenger RNA
18%
Sample
17%
Sequencing
16%
Next Generation Sequencing
16%
Indel
16%
B Cell
14%
Amplicon
14%
Ibrutinib
14%
Bioinformatics
11%
Survival
10%
Association
10%
Nested Gene
10%
DNA
9%
Myeloid
9%
Development
8%
Single-Nucleotide Polymorphism
8%
Polymerase Chain Reaction
8%
Gene Frequency
8%
Yeast
7%
Experiment
7%
Gene Control
7%
Bone
7%
Factor V Leiden
7%
Accuracy
7%
Writing
7%
Janus Kinase 2
7%
Cystic Fibrosis Transmembrane Conductance Regulator
7%
Thiazolidinedione
7%
Southern Blotting
7%
Locus Control Region
7%
Probe
7%
PRDM1
7%
Cell Metabolism
7%
Missense Mutation
7%
RNA Splicing
7%
Circulating Tumor DNA
7%
IRF1
7%
Case Report
7%
Fusion Gene
7%
Isochromosome
7%
Mortality
7%
Haplotype
7%
Bcl-2-Associated X Protein
7%
Myeloid
7%
Essential Thrombocythaemia
7%
Platelet Derived Growth Factor Receptor Alpha
7%
AKAP9
7%
Spliceosome
6%
Pharmacology, Toxicology and Pharmaceutical Science
Ibrutinib
29%
Chronic Lymphatic Leukemia
29%
Peroxisome Proliferator Activated Receptor
22%
Neoplasm
19%
Survival
16%
Bruton Tyrosine Kinase
16%
Polycythemia vera
14%
Cerdulatinib
14%
Mantle Cell Lymphoma
14%
Apoptosis
14%
Drug
13%
Protein
10%
B Lymphocyte Receptor
9%
Clinical Trial
8%
B Cell Lymphoma
8%
Biological Marker
8%
Malignant Neoplasm
8%
Busulfan
7%
Diffuse Large B Cell Lymphoma
7%
Venetoclax
7%
Selinexor
7%
Phosphotransferase Inhibitor
7%
T Cell Lymphoma
7%
Protein Tyrosine Kinase Inhibitor
7%
Paraffin
7%
Dasatinib
7%
Blood Clotting Factor 5 Leiden
7%
Breast Carcinoma
7%
Interferon Regulatory Factor 1
7%
Cerdulatinib
7%
Ibrutinib
7%
Protein Bax
7%
Herpesviridae
7%
B Lymphocyte Receptor
7%
Phosphotransferase
6%
Cell Death
6%